...
首页> 外文期刊>Case Reports in Hematology >Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma
【24h】

Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma

机译:自发性脾破裂和蓖麻诱导的患者在高危地幔细胞淋巴瘤的患者中诱导的急性血小板减少症

获取原文
           

摘要

Mantle cell lymphoma is a relatively rare type of mature B-cell non-Hodgkin’s lymphoma with an incidence of approximately 8 cases per million persons per year. In patients with mantle cell lymphoma, there are rare case reports of the potentially life-threatening consequences of splenic rupture and rituximab-induced acute thrombocytopenia (RIAT) occurring separately, but there are no reports of these occurring in the same patient. Whilst rare, they are important to be aware of as early detection may prevent fatal outcomes.
机译:地幔细胞淋巴瘤是一种相对罕见的成熟B细胞非霍奇金淋巴瘤,每年百万人的发病率约为8例。在患有伴细胞淋巴瘤的患者中,有罕见的含有危及脾脏破裂和急性血小板减少症(RIZ)的潜在危及危及危及急性血小板减少(RAT),但在同一患者中没有报道。虽然罕见,但由于早期检测可能预防致命结果非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号